NMPA Approval

Doxazosin Mesylate Extended Release Tablets

Approval Number

国药准字H20103571

Company合肥立方制药股份有限公司

Registration Date

August 5, 2020

Previous Approval Numbers

国药准字H20103571

Drug Information

Generic Name

甲磺酸多沙唑嗪缓释片

Brand Name

立衡

Dosage Form

片剂(缓释片)

Strength

4mg(按C₂₃H₂₅N₅O₅计)

Drug Type

化学药品

Registration Date

August 5, 2020

Company Information

Applicant Company

Company Name合肥立方制药股份有限公司

Company Address

合肥市长江西路669号立方厂区

Manufacturing Company

Company Name合肥立方制药股份有限公司

Company Address

合肥市高新区文曲路446号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪缓释片 - NMPA 批准文号 | MedPath